CRISPR-based diagnostics detects invasive insect pests

被引:5
|
作者
Shashank, Pathour R. [1 ,2 ]
Parker, Brandon M. [1 ,3 ,4 ]
Rananaware, Santosh R. [5 ]
Plotkin, David [1 ]
Couch, Christian [1 ]
Yang, Lilia G. [5 ]
Nguyen, Long T. [5 ]
Prasannakumar, N. R. [6 ]
Braswell, W. Evan [7 ]
Jain, Piyush K. [3 ,8 ,9 ]
Kawahara, Akito Y. [1 ]
机构
[1] Univ Florida, McGuire Ctr Lepidoptera & Biodivers, Florida Museum Nat Hist, Gainesville, FL 32611 USA
[2] ICAR Indian Agr Res Inst, Div Entomol, New Delhi, India
[3] Oak Ridge Inst Sci Educ, Oak Ridge, TN USA
[4] US EPA, Off Res & Dev, Res Triangle Pk, NC USA
[5] Univ Florida, Dept Chem Engn, Gainesville, FL USA
[6] ICAR Indian Inst Hort Res, Div Crop Protect, Bengaluru, India
[7] USDA APHIS PPQ S&T, Insect Management & Mol Diagnost Lab, Edinburg, TX USA
[8] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA
[9] Univ Florida, UF Hlth Canc Ctr, Gainesville, FL USA
基金
美国农业部; 美国国家卫生研究院;
关键词
Cas12a; CRISPR; diagnostics; genetic identification; Keiferia lycopersicella; leaf miner; Phthorimaea absoluta; RPA; Scrobipalpa atriplicella; Tuta absoluta; ENVIRONMENTAL DNA; MISIDENTIFICATION; LIFE; PCR;
D O I
10.1111/1755-0998.13881
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rapid identification of organisms is essential for many biological and medical disciplines, from understanding basic ecosystem processes, disease diagnosis, to the detection of invasive pests. CRISPR-based diagnostics offers a novel and rapid alternative to other identification methods and can revolutionize our ability to detect organisms with high accuracy. Here we describe a CRISPR-based diagnostic developed with the universal cytochrome-oxidase 1 gene (CO1). The CO1 gene is the most sequenced gene among Animalia, and therefore our approach can be adopted to detect nearly any animal. We tested the approach on three difficult-to-identify moth species (Keiferia lycopersicella, Phthorimaea absoluta and Scrobipalpa atriplicella) that are major invasive pests globally. We designed an assay that combines recombinase polymerase amplification (RPA) with CRISPR for signal generation. Our approach has a much higher sensitivity than real-time PCR assays and achieved 100% accuracy for identification of all three species, with a detection limit of up to 120 fM for P. absoluta and 400 fM for the other two species. Our approach does not require a sophisticated laboratory, reduces the risk of cross-contamination, and can be completed in less than 1 h. This work serves as a proof of concept that has the potential to revolutionize animal detection and monitoring.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] CRISPR-based genetic control strategies for insect pests
    Ying YAN
    Roswitha A. AUMANN
    Irina H?CKER
    Marc F. SCHETELIG
    Journal of Integrative Agriculture, 2023, 22 (03) : 651 - 668
  • [2] CRISPR-based genetic control strategies for insect pests
    Yan, Ying
    Aumann, Roswitha A.
    Haecker, Irina
    Schetelig, Marc F.
    JOURNAL OF INTEGRATIVE AGRICULTURE, 2023, 22 (03) : 651 - 668
  • [3] CRISPR-based diagnostics
    Hannah Stower
    Nature Medicine, 2018, 24 : 702 - 702
  • [4] CRISPR-based diagnostics
    Stower, Hannah
    NATURE MEDICINE, 2018, 24 (06) : 702 - 702
  • [5] CRISPR-based diagnostics
    Michael M. Kaminski
    Omar O. Abudayyeh
    Jonathan S. Gootenberg
    Feng Zhang
    James J. Collins
    Nature Biomedical Engineering, 2021, 5 : 643 - 656
  • [6] CRISPR-based diagnostics
    Kaminski, Michael M.
    Abudayyeh, Omar O.
    Gootenberg, Jonathan S.
    Zhang, Feng
    Collins, James J.
    NATURE BIOMEDICAL ENGINEERING, 2021, 5 (07) : 643 - 656
  • [7] Portable CRISPR-based diagnostics
    Nature Biotechnology, 2019, 37 : 832 - 832
  • [8] Portable CRISPR-based diagnostics
    不详
    NATURE BIOTECHNOLOGY, 2019, 37 (08) : 832 - 832
  • [9] CRISPR-Based Tool Detects Viral DNA
    不详
    CHEMICAL ENGINEERING PROGRESS, 2018, 114 (03) : 11 - 11
  • [10] CRISPR-based diagnostics for detection of pathogens
    Bhattacharjee, Gargi
    Gohil, Nisarg
    Lam, Navya Lavina
    Singh, Vijai
    REPROGRAMMING THE GENOME: CRISPR-CAS-BASED HUMAN DISEASE THERAPY, 2021, 181 : 45 - 57